Abstract Background and Objective Both bronchoscopic lung volume reduction with
endobronchial valves (BLVR‐EBV) and pulmonary rehabilitation (PR) are effective …

Objective To contribute to the knowledge on the therapeutic value of lung volume reduction
surgery (LVRS) Design Two similar, independently conceived and conducted, multicenter …

It is an interesting time for the management of emphysema. In this condition, destruction of
lung parenchyma associated with reduced elastic recoil and dynamic airways closure …

Background: Patients who achieve significant target lobe volume reduction (TLVR) following
endobronchial valve (EBV) treatment may experience substantial improvements in clinical …

Background Bronchoscopic lung-volume reduction with the use of one-way endobronchial
valves is a potential treatment for patients with severe emphysema. To date, the benefits …

Chronic obstructive pulmonary disease (COPD) is a progressive condition comprising a
constellation of disorders from chronic bronchitis, airflow obstruction through to emphysema …

Endoscopic lung volume reduction (ELVR) therapies are gaining prominence as a treatment
option with guideline recommendations by COPD GOLD and NICE and the recent FDA …

Endobronchial valve (EBV) therapy may be associated with improvements in chronic
obstructive pulmonary disease-related outcomes and may therefore be linked to …

Lung volume reduction surgery (LVRS) produces physiological, symptomatic, and survival
benefits in selected patients with advanced emphysema. Because it is associated with …

Study objectives Current data for patients> 2 years after lung volume reduction surgery
(LVRS) for emphysema is limited. This prospective study evaluates pre-LVRS baseline data …